Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 02 Mar 2022

A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy

in Thoracic Oncology

Maosong Ye
Lin Tong
Xiaoxuan Zheng
Hui Wang
Haining Zhou
Xiaoli Zhu
Chengzhi Zhou
Peige Zhao
Yan Wang
Qi Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.853801

10,258 views
41 citations

Original Research

Published on 02 Mar 2022

Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity

in Thoracic Oncology

Jing Qi
Jiaqi Zhang
Ningbo Liu
Lujun Zhao
Bo Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.779276

9,270 views
45 citations

Systematic Review

Published on 28 Feb 2022

Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett’s Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials

in Thoracic Oncology

Yizi Wang
Bin Ma
Shize Yang
Wenya Li
Peiwen Li

Frontiers in Oncology

doi 10.3389/fonc.2022.801940

4,571 views
6 citations

Original Research

Published on 28 Feb 2022

Impact of an Embedded Palliative Care Clinic on Healthcare Utilization for Patients With a New Thoracic Malignancy

in Thoracic Oncology

Kelly C. Gast
Jason A. Benedict
Madison Grogan
Sarah Janse
Maureen Saphire
Pooja Kumar
Erin M. Bertino
Julia L. Agne
Carolyn J. Presley

Frontiers in Oncology

doi 10.3389/fonc.2022.835881

3,890 views
13 citations

Original Research

Published on 28 Feb 2022

Genomic And Tumor Microenvironment Differences Between Cell Cycle Progression Pathway Altered/Non-Altered Patients With Lung Adenocarcinoma

in Thoracic Oncology

Guangyao Shan
Guoshu Bi
Yunyi Bian
Besskaya Valeria
Dejun Zeng
Huan Zhang
Guangyu Yao
Yi Zhang
Hong Fan
Cheng Zhan

Frontiers in Oncology

doi 10.3389/fonc.2022.843528

4,144 views
8 citations

Correction

Published on 25 Feb 2022

Corrigendum: Identification and Validation Prognostic Impact of miRNA-30a-5p in Lung Adenocarcinoma

in Thoracic Oncology

Xiulin Jiang
Yixiao Yuan
Lin Tang
Juan Wang
Dahang Zhang
William C. Cho
Lincan Duan

Frontiers in Oncology

doi 10.3389/fonc.2022.862076

1,437 views

Original Research

Published on 25 Feb 2022

Biomarker Testing Patterns and Treatment Outcomes in Patients With Advanced Non-Small Cell Lung Cancer and MET Exon 14 Skipping Mutations: A Descriptive Analysis From the US

in Thoracic Oncology

Fatemeh Asad Zadeh Vosta Kolaei
Beilei Cai
Hemanth Kanakamedala
Julia Kim
Vitalii Doban
Shiyu Zhang
Michael Shi

Frontiers in Oncology

doi 10.3389/fonc.2022.786124

5,724 views
5 citations

Original Research

Published on 23 Feb 2022

LncRNA-AC068228.1 Is a Novel Prognostic Biomarker That Promotes Malignant Phenotypes in Lung Adenocarcinoma

in Thoracic Oncology

Xiulin Jiang
Min Chen
Junyi Du
Hong Bi
Xiang Guo
Chao Yang
Xu He
Zhixian Jin

Frontiers in Oncology

doi 10.3389/fonc.2022.856655

2,910 views
4 citations

Opinion

Published on 23 Feb 2022

A “SHort course Accelerated RadiatiON therapy” (SHARON) During and Beyond the COVID-19 Pandemic

in Thoracic Oncology

Alessio G. Morganti
Gabriella Macchia
Francesco Cellini
Francesco Deodato
Alice Zamagni
Giambattista Siepe
Milly Buwenge

Frontiers in Oncology

doi 10.3389/fonc.2022.823445

2,205 views
2 citations

Original Research

Published on 23 Feb 2022

Establishing a Macrophage Phenotypic Switch-Associated Signature-Based Risk Model for Predicting the Prognoses of Lung Adenocarcinoma

in Thoracic Oncology

Jun Chen
Chao Zhou
Ying Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.771988

5,292 views
3 citations

Original Research

Published on 23 Feb 2022

Application Value of PET/CT and MRI in the Diagnosis and Treatment of Patients With Synchronous Multiple Pulmonary Ground-Glass Nodules

in Thoracic Oncology

Shaonan Xie
Shaoteng Li
Huiyan Deng
Yaqing Han
Guangjie Liu
Qingyi Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.797823

3,218 views
2 citations

Original Research

Published on 22 Feb 2022

The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer

in Thoracic Oncology

Jun Cai
Huihui Jiang
Shuqing Li
Xiaoxia Yan
Meng Wang
Na Li
Cuimin Zhu
Hui Dong
Dongjuan Wang
Yue Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.751106

8,874 views
14 citations

Original Research

Published on 18 Feb 2022

Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size

in Thoracic Oncology

Weijia Huang
Han-Yu Deng
Ming-Ying Lin
Kai Xu
Yu-Xiao Zhang
Chi Yuan
Qinghua Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.830470

6,225 views
26 citations

Original Research

Published on 18 Feb 2022

Ciclopirox Olamine Exerts Tumor-Suppressor Effects via Topoisomerase II Alpha in Lung Adenocarcinoma

in Thoracic Oncology

Jie Yin
Gang Che
Kan Jiang
Ziyang Zhou
Lingyun Wu
Mengyou Xu
Jian Liu
Senxiang Yan

Frontiers in Oncology

doi 10.3389/fonc.2022.791916

4,971 views
14 citations

Review

Published on 16 Feb 2022

Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies

in Thoracic Oncology

Anne-Laure Désage
Camille Léonce
Aurélie Swalduz
Sandra Ortiz-Cuaran

Frontiers in Oncology

doi 10.3389/fonc.2022.796832

20,408 views
55 citations

Original Research

Published on 16 Feb 2022

Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer

in Thoracic Oncology

Yongfei Fan
Yong Zhou
Xinwei Li
Ming Lou
Zhaojia Gao
Kai Yuan
Jichun Tong

Frontiers in Oncology

doi 10.3389/fonc.2022.781903

3,782 views
6 citations

Original Research

Published on 14 Feb 2022

Cetuximab Combined With Sonodynamic Therapy Achieves Dual-Modal Image Monitoring for the Treatment of EGFR-Sensitive Non-Small-Cell Lung Cancer

in Thoracic Oncology

Guanhua Qiu
Lianfang Xue
Xiaoqi Zhu
Xiuxin Lu
Lidong Liu
Zhonghai Wang
Xiangdong Li
Cuiqing Huang
Junjie Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.756489

4,374 views
10 citations

Original Research

Published on 14 Feb 2022

Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma： A Retrospective Study

in Thoracic Oncology

Yi Xiao
Jinyuan He
Shaoning Luo
Min Dong
Wei Li
Gaijiao Liu
Hongjie Chen
Xiongwen Yang
Shaohong Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.820302

8,368 views
27 citations

Review

Published on 11 Feb 2022

Therapeutic Potential of Glutamine Pathway in Lung Cancer

in Thoracic Oncology

Enyu Tang
Siyang Liu
Zhiming Zhang
Rixin Zhang
Dejing Huang
Tong Gao
Tianze Zhang
Guangquan Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.835141

8,631 views
16 citations

Original Research

Published on 11 Feb 2022

The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase Inhibitors

in Thoracic Oncology

Guangjian Yang
Chengming Liu
Jiaqi Hu
Yang Sun
Peizeng Hu
Liu Liu
Haiyan Xu
Dazhou Li
Weihua Li
Yaning Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.843299

7,698 views
12 citations

Original Research

Published on 10 Feb 2022

Optimal Initial Time Point of Local Radiotherapy for Unresectable Lung Adenocarcinoma: A Retrospective Analysis on Overall Arrangement of Local Radiotherapy in Advanced Lung Adenocarcinoma

in Thoracic Oncology

Xinge Li
Jie Wang
Xu Chang
Zhenhua Gao
Feifei Teng
Xue Meng
Jinming Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.793190

3,264 views
3 citations

Brief Research Report

Published on 10 Feb 2022

Use of Pralsetinib as Neoadjuvant Therapy for Non-Small Cell Lung Cancer Patient With RET Rearrangement

in Thoracic Oncology

Ning Zhou
Tong Li
Maoli Liang
Fan Ren
Hong Ni
Wei Liu
Tao Shi
Dongbo Xu
Qiusong Chen
Haonan Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.848779

5,146 views
17 citations

Review

Published on 09 Feb 2022

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC

in Thoracic Oncology

Fenglong Bie
He Tian
Nan Sun
Ruochuan Zang
Moyan Zhang
Peng Song
Lei Liu
Yue Peng
Guangyu Bai
Bolun Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.769124

10,904 views
42 citations

Correction

Published on 09 Feb 2022

Corrigendum: High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors

in Thoracic Oncology

Paul Takam Kamga
Aurélie Swalduz
Adrien Costantini
Catherine Julié
Jean-François Emile
Maurice Pérol
Virginie Avrillon
Sandra Ortiz-Cuaran
Pierre De Saintigny
Etienne Giroux-Leprieur

Frontiers in Oncology

doi 10.3389/fonc.2022.852540

1,433 views
1 citation

1,969 articles

articles

A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy

Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity

Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett’s Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials

Impact of an Embedded Palliative Care Clinic on Healthcare Utilization for Patients With a New Thoracic Malignancy

Genomic And Tumor Microenvironment Differences Between Cell Cycle Progression Pathway Altered/Non-Altered Patients With Lung Adenocarcinoma

Corrigendum: Identification and Validation Prognostic Impact of miRNA-30a-5p in Lung Adenocarcinoma

Biomarker Testing Patterns and Treatment Outcomes in Patients With Advanced Non-Small Cell Lung Cancer and MET Exon 14 Skipping Mutations: A Descriptive Analysis From the US

LncRNA-AC068228.1 Is a Novel Prognostic Biomarker That Promotes Malignant Phenotypes in Lung Adenocarcinoma

A “SHort course Accelerated RadiatiON therapy” (SHARON) During and Beyond the COVID-19 Pandemic

Establishing a Macrophage Phenotypic Switch-Associated Signature-Based Risk Model for Predicting the Prognoses of Lung Adenocarcinoma

Application Value of PET/CT and MRI in the Diagnosis and Treatment of Patients With Synchronous Multiple Pulmonary Ground-Glass Nodules

The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer

Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size

Ciclopirox Olamine Exerts Tumor-Suppressor Effects via Topoisomerase II Alpha in Lung Adenocarcinoma

Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies

Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer

Cetuximab Combined With Sonodynamic Therapy Achieves Dual-Modal Image Monitoring for the Treatment of EGFR-Sensitive Non-Small-Cell Lung Cancer

Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma： A Retrospective Study

Therapeutic Potential of Glutamine Pathway in Lung Cancer

The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase Inhibitors

Optimal Initial Time Point of Local Radiotherapy for Unresectable Lung Adenocarcinoma: A Retrospective Analysis on Overall Arrangement of Local Radiotherapy in Advanced Lung Adenocarcinoma

Use of Pralsetinib as Neoadjuvant Therapy for Non-Small Cell Lung Cancer Patient With RET Rearrangement

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC

Corrigendum: High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors